What MDI Limbach Berlin does

MDI Limbach Berlin GmbH is a Berlin-based medical diagnostic laboratory (Medizinisch-Diagnostisches Institut) operating since 1948 and integrated into the Limbach Gruppe SE in 2016. The company provides a comprehensive range of accredited laboratory services — laboratory medicine, microbiology, molecular diagnostics (PCR), toxicology, transfusion medicine, and human genetics — from a 3,500+ m² facility at Aroser Allee 84 in Berlin-Reinickendorf, supported by six additional hospital-based laboratory sites across the city. It serves more than 1,200 referring physicians and over 10 hospitals in Berlin and Brandenburg, processing approximately 1.58 million laboratory orders annually, with DIN EN ISO 15189:2024 accreditation and §20b AMG authorization for fertility and in vitro diagnostics.

The business is built around a physician- and hospital-centric B2B model. Revenue is generated primarily through statutory health insurance (GKV) billing under the German EBM scale via the Kassenärztliche Vereinigung Berlin, supplemented by private patient (PKV/GOÄ) billing, self-pay IGeL services (including direct patient blood draws via Doctolib), hospital managed-services contracts, and ancillary practice material sales through the MTU webshop. Proprietary technology infrastructure includes lab@ccess (Limbach Gruppe's digital order entry and results management platform) with LDT and HL7 integrations into physician practice management systems, plus a temperature-controlled sample logistics network operated with partner M+F. The Außendienst of seven named field representatives provides on-site practice support, while a service center handles inbound customer inquiries.

The company is a private GmbH with no public equity listing. It faces structural margin pressure from German regulatory fee reforms — a 2025 EBM reform cut laboratory examination fees by approximately 10%, and 2026 GOÄ reform proposals have triggered public opposition from the company on patient-safety grounds. Recent strategic activity is incremental and defensive: a March 2026 platform transition for free light chain analysis, a planned Q4 2026 Laboratory Information System upgrade, and Doctolib-enabled direct-patient channel expansion.

Name

MDI Limbach Berlin

Legal name

MDI Limbach Berlin GmbH

Website

https://mdi-limbach-berlin.de

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

101–250 employees

Short description

MDI Limbach Berlin GmbH is a DIN EN ISO 15189:2024-accredited medical diagnostic laboratory serving 1,200+ physicians and 10+ hospitals in Berlin and Brandenburg, processing ~1.58M orders/year across routine and specialty diagnostics.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

akta.pro secondary industries

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)

Keywords

• Medical laboratory diagnostics
• Clinical laboratory services
• Microbiology testing
• Molecular diagnostics PCR
• Hospital laboratory management

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Statutory Health Insurance (GKV) Laboratory Services: Billed through the German Uniform Value Scale (EBM) under contracts with the Kassenärztliche Vereinigung (KV) Berlin. Laboratory diagnostic services provided to insured patients are reimbursed according to the KV fee schedule.
2. Private Patient (PKV/GÖÄ) Laboratory Services: Billed under the German Scale of Fees for Physicians (GOÄ) for private patients. The company has publicly opposed proposed GOÄ reforms that would threaten the economic viability of laboratory diagnostics.
3. Individual Health Services (IGeL): Self-pay laboratory services offered directly to patients, including blood draws and swabs at the laboratory location, priced according to GOÄ.
4. Hospital Laboratory Services: Comprehensive laboratory management and diagnostic services for hospitals, including outsourcing/insourcing of laboratory operations, electronic order entry, and on-site specialist support.
5. Practice Material Sales: Sale of practice supplies and sample collection materials through the MTU (Medical Trading Unit) webshop, part of the Limbach Gruppe.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

MDI Limbach Berlin is a DIN EN ISO 15189:2024 accredited medical diagnostic laboratory providing comprehensive laboratory medicine services across Berlin and Brandenburg. The company delivers routine and specialized testing in laboratory medicine, microbiology, molecular diagnostics (PCR), toxicology, transfusion medicine, and human genetics to more than 1,200 referring physicians, 10+ hospitals, dialysis centers, occupational health providers, and research institutes. Diagnostic services are supported by the lab@ccess electronic order entry system, dedicated field sales, sample logistics, electronic result transmission, and compliance-grade preanalytics.

Product overview

MDI Limbach Berlin operates as a multi-site medical diagnostic laboratory (Medizinisch-Diagnostische Institute) providing comprehensive laboratory medicine services across Berlin and Brandenburg. The core offering is its ISO 15189:2024 accredited laboratory diagnostic services, which span laboratory medicine, microbiology, molecular diagnostics (PCR), toxicology, transfusion medicine, and quality management. These services are delivered through three hospital-based lab sites (Labor Jüdisches Krankenhaus, Labor St. Joseph Krankenhaus, Labor Waldfriede Krankenhaus, Labor Krankenhaus Hedwigshöhe, Labor St. Hedwig-Krankenhaus) and a main facility at Aroser Allee. The digital front-end is centered on lab@ccess, the proprietary Order Entry system of the Limbach Gruppe, which enables electronic order transmission and result retrieval for over 1,200 referring physicians and 10 hospitals. Supporting services include sample logistics (courier), electronic data transfer (LDT/HL7), a patient report portal (available in German and English), medical calculators, preanalytics support, billing services, remote IT maintenance, and infection protection reporting. The laboratory is part of the Limbach Gruppe SE, a network of 35 laboratories with over 6,000 employees across Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• lab@ccess Order Entry System Digital Order Entry system developed by the Limbach Gruppe that enables physician practices to electronically transmit laboratory orders and receive results. Allows order creation in two clicks and provides real-time result delivery. Free for referring practices; requires internet-connected computer.
• MDI Limbach Berlin Laboratory Diagnostics

Quantifiable outcome

• Over 1,580,000 laboratory orders processed annually
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Limbach Gruppe SEcoreOthersMDI Limbach Berlin GmbH was integrated into the Limbach Gruppe SE in 2016. The Limbach Gruppe is the largest owner-operated network of physician laboratories in Germany, with over 35 laboratory locations and more than 6,000 employees. MDI Limbach Berlin operates under the Limbach Gruppe umbrella, benefiting from shared diagnostic platforms, the lab@ccess IT system, purchasing power through MTU, and access to specialist expertise across the network. Dr. med. Patricia Geller, a member of the Limbach Gruppe SE board, also serves as Managing Director of MDI Limbach Berlin.
• IU Internationale Hochschule GmbH (IU / formerly IUBH)minorStrategic or Co-development PartnerPartnership with IU Internationale Hochschule GmbH for dual study programs in the fields of Human Resources, Marketing, and Healthcare Management. IU is described as a cooperation partner for dual study programs.
• Deutsches Rotes Kreuz, Landesverband Berliner Rotes Kreuz e.V.minorStrategic or Co-development PartnerPartnership with the German Red Cross (DRK) Berlin chapter for the Voluntary Social Year (FSJ / Freiwilliges Soziales Jahr) program, providing opportunities for young people to volunteer in healthcare settings.
• M+F (Logistics Partner)coreOthersM+F is the specialized logistics partner for medical specimen transport. MDI Limbach Berlin's sample pickup service (Fahrdienst) is operated in close coordination with M+F, whose dispatch office is located near the laboratory premises. M+F provides trained drivers, temperature-controlled vehicles, and compliance with DIN EN ISO 15189 and TRBA 100 transport requirements.
• MTU (Medical Trading Unit) — Limbach GruppecoreChannel Partner/ Reseller/ DistributorMTU is a subsidiary of the Limbach Gruppe responsible for supplying laboratory and practice materials to Limbach laboratory customers. Through the MTU webshop, physician practices can order sample collection materials (tubes, culture media, etc.) with most items provided free of charge for referring practices.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Synlab: Europe's largest medical diagnostic services provider, headquartered in Germany, offering clinical laboratory testing across all major specialties with very similar service lines (microbiology, molecular diagnostics, genetics, toxicology) and a comparable multi-site reference lab model.
• Cerba Healthcare: European leader in clinical pathology and specialty diagnostics, particularly strong in specialty reference lab services — comparable to MDI Limbach Berlin's hospital reference lab and specialty testing positioning.
• Medicover: International healthcare and diagnostics provider with significant European laboratory operations — overlaps with MDI Limbach Berlin on clinical lab services and hospital/reference lab customer base.
• Unilabs: Major European clinical diagnostics provider delivering laboratory and specialty testing services — comparable in service breadth, customer types, and reference lab operations.

Direct peers

• Labor Berlin: Hospital-affiliated medical laboratory serving Charité and Vivantes in Berlin, providing the same breadth of clinical diagnostics and serving the same Berlin-area referring physician and hospital market as MDI Limbach Berlin.
• amedes: Germany-based medical diagnostics network operating laboratory and physician practice sites with analogous specialty coverage in laboratory medicine, microbiology, and genetics — directly comparable service portfolio and customer types to MDI Limbach Berlin.
• MVZ Labor Volkmann: Regional German medical laboratory offering clinical chemistry, microbiology, molecular diagnostics, and transfusion medicine to physicians and hospitals — a directly comparable mid-sized German lab.
• LADR Der Laborverbund: Cooperative network of physician-led medical laboratories in Germany providing clinical chemistry, microbiology, immunology, and molecular diagnostics — a direct functional peer to MDI Limbach Berlin's reference lab model.

Others

• Sonic Healthcare: Global medical diagnostics group operating reference laboratory networks across multiple geographies — overlaps with MDI Limbach Berlin on clinical lab operations and physician/hospital customer segments.
• Helios Kliniken: Largest private hospital operator in Germany with in-house laboratory operations and procurement needs that interact closely with the external reference lab industry — relevant adjacent peer given MDI Limbach Berlin's hospital lab outsourcing business model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mdi-limbach-berlin-gmbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MDI Limbach Berlin